Download PDF
Endo-Praxis 2024; 40(02): 87-95
DOI: 10.1055/a-2302-2479
Weiterbildung

Update Barrett-Ösophagus

Hendrik Manner
› Further Information
Also available at
    Permissions and Reprints

Das Thema Barrett-Ösophagus begleitet uns bereits geraume Zeit im klinischen Alltag. In den 70er-Jahren wurde der Zusammenhang mit dem gastroösophagealen Reflux erkannt, 10 Jahre später mit dem Adenokarzinom des Ösophagus. Ab den 90er-Jahren nahm das Thema Barrett-Ösophagus rasant an Fahrt auf. Die endoskopischen Möglichkeiten in Diagnostik und Therapie entwickelten sich schnell weiter. Patienten mit einem Barrett-Ösophagus werden heute individualisiert überwacht und therapiert. Aktuell wird das diagnostische Spektrum durch die faszinierenden Möglichkeiten der künstlichen Intelligenz erweitert.



Publication History

Article published online:
14 May 2024

© 2024. Thieme. All rights reserved.

Georg Thieme Verlag
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • Literatur

  • 1 Eusebi LH, Cirota GG, Zagari RM. et al. Global prevalence of Barrett’s esophagus and oesophageal cancer in individuals with gastro-oesophageal reflux: a systematic review and meta-analysis. Gut 2021; 70: 456-463
    CrossrefPubMedGoogle Scholar
  • 2 Allen JE, Desai M, Roumans CAM. et al. Low risk of progression of Barrett’s esophagus to neoplasia in women. J Clin Gastroenterol 2021; 55: 321-326
    CrossrefPubMedGoogle Scholar
  • 3 Koop H, Fuchs KH, Labenz J. et al. S2k-Leitlinie: Gastroösophageale Refluxkrankkheit unter Federführung der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS). Z Gastroenterol 2014; 52: 1299-1346
    Article in Thieme ConnectPubMedGoogle Scholar
  • 4 Weusten B, Bisschops R, Coron E. et al. Endoscopic management of Barrett’s esophagus: European Society of Gastrointestinal. Endoscopy (ESGE) Position Statement. Endoscopy 2017; 49: 191-198
    PubMedGoogle Scholar
  • 5 Behrens A, Pech O, Wuthnow E. et al. Detection of early neoplasia in Barrett’s esophagus: focus attention on index endoscopy in short-segment-Barrett’s esophagus with random biopsies. Z Gastroenterol 2015; 53: 568-572
    PubMedGoogle Scholar
  • 6 Leitlinienprogramm Onkologie. S3-Leitlinie Diagnostik und Therapie der Plattenepithelkarzinome und Adenokarzinome des Ösophagus (Version 3). AWMF-Registernummer 021/0230L. Im Internet: https://www.leitlinienprogramm-onkologie.de/fileadmin/user_upload/Downloads/Leitlinien/Oesophaguskarzinom/Version_3/LL_%C3%96sophaguskarzinom_Langversion_3.1.pdf; Stand: 17.10.2022
  • 7 Qumseya BJ, Wang H, Badie N. et al. Advanced imaging technologies increase detection of dysplasia and neoplasia in patients with Barrett’s esophagus: a meta-analysis and systematic review. Clin Gastroenterol Hepatol 2013; 11: 1562-1570.e1-2
    CrossrefPubMedGoogle Scholar
  • 8 Kandiah K, Chedgy FJG, Subramaniam S. et al. International development and validation of a classification system for the identification of Barrett’s neoplasia using acetic acid chromoendoscopy: the Portsmouth acetic acid classification (PREDICT). Gut 2018; 67: 2085-2091
    CrossrefPubMedGoogle Scholar
  • 9 Sharma P, Bergman JGHM, Goda K. et al. Development and validation of a classification system to identify high-grade dysplasia and esophageal adenocarcinoma in Barrett’s esophagus using narrow-band imaging. Gastroenterology 2016; 150: 591-598
    CrossrefPubMedGoogle Scholar
  • 10 Struyvenberg MR, de Groof AJ, van der Putten J. et al. A computerassisted algorithm for narrow-band imaging-based tissue characterization in Barrett’s esophagus. Gastrointest Endosc 2021; 93: 89-98
    CrossrefPubMedGoogle Scholar
  • 11 Hashimoto R, Requa J, Dao T. et al. Artificial intelligence using convolutional neuronal networks for real-time detection of early esophageal neoplasia in Barrett’s esophagus. Gastrointest Endosc 2020; 91: 1264-1271
    CrossrefPubMedGoogle Scholar
  • 12 Omidvari AH, Hazelton WD, Lauren BN. et al. The optimal age to stop endoscopic surveillance of patients with Barrett’s esophagus based on sex and comorbidity: a comparative costeffectiveness analysis. Gastroenterology 2021; 161: 487-494
    CrossrefPubMedGoogle Scholar
  • 13 Pech O, May A, Manner H. et al. Long-term efficacy and safety of endoscopic resection for patients with mucosal adenocarcinoma of the esophagus. Gastroenterology 2014; 146: 652-660
    CrossrefPubMedGoogle Scholar
  • 14 Manner H, Rabenstein T, Pech O. et al. Ablation of residual Barrett’s epithelium after endoscopic resection: a randomized long-term follow-up study of argon plasma coagulation vs. surveillance (APE study). Endoscopy 2014; 46: 6-12
    PubMedGoogle Scholar
  • 15 Pouw R, Klaver E, Phoa KN. et al. Radiofrequency ablation for low-grade dysplasia in Barrett’s esophagus: long-term outcome of a randomized trial. Gastrointest Endosc 2020; 92: 569-574
    CrossrefPubMedGoogle Scholar
  • 16 Manner H, Pech O, Heldmann Y. et al. Efficacy, safety, and long-term results of endoscopic treatment for the early stage adenocarcinoma of the esophagus with low-risk sm1 invasion. Clin Gastroenterol Hepatol 2013; 11: 630-635
    CrossrefPubMedGoogle Scholar
  • 17 Pimentel-Nunes P, Libanio D, Bastiaansen BAJ. et al. Endoscopic submucosal dissection for superficial gastrointestinal lesions: European Society of Gastrointestinal Endoscopy (ESGE) Guideline – Update 2022. Endoscopy 2022; 54: 591-622
    Article in Thieme ConnectPubMedGoogle Scholar
  • 18 Manner H, May A, Kouti I. et al. Efficacy and safety of Hybrid-APC for the ablation of Barrett’s esophagus. Surg Endosc 2016; 30: 1364-1370
    CrossrefPubMedGoogle Scholar
  • 19 Knabe M, Beyna T, Rösch T. et al. Hybrid-APC in combination with resection for the endoscopic treatment of neoplastic Barrett’s esophagus: a prospective multicenter study. Am J Gastroenterol 2022; 117: 110-119
    CrossrefPubMedGoogle Scholar